US Oncology Drugs Market to Reach USD 412.2 Billion by 2030 at 15.51% CAGR
The U.S. Oncology Drugs Market is undergoing a powerful transformation, driven by rapid scientific innovation, rising cancer prevalence, and increasing demand for personalized treatments. Valued at USD 150.2 billion in 2023, the market is projected to reach nearly USD 412.2 billion by 2030, expanding at a strong CAGR of 15.51%.
Rising Cancer Burden Driving Demand...